The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4642313)

Published in Sci Rep on November 12, 2015

Authors

Rosamaria Capuano1, Marco Santonico2, Giorgio Pennazza2, Silvia Ghezzi1, Eugenio Martinelli1, Claudio Roscioni3, Gabriele Lucantoni3, Giovanni Galluccio3, Roberto Paolesse4, Corrado Di Natale1, Arnaldo D'Amico1

Author Affiliations

1: Department of Electronic Engineering, University of Rome Tor Vergata, Via del Politecnico 1, 00133 Rome, Italy.
2: Center for Integrated Research - CIR, Unit of Electronics for Sensor Systems, "Università Campus Bio-Medico di Roma", via Álvaro del Portillo 21, 00128 Rome, Italy.
3: S. Camillo - C. Forlanini Hospital, Circ.ne Gianicolense 87, 00152 Rome, Italy.
4: Department of Chemical Science and Technology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy.

Articles cited by this

Structure and chemistry of cytochrome P450. Chem Rev (2005) 5.85

Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70

Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol (2009) 3.16

Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94

Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron (2003) 2.72

Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer (2010) 2.35

An investigation on electronic nose diagnosis of lung cancer. Lung Cancer (2009) 1.85

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer (2008) 1.80

Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res (2005) 1.68

Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54

Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev (2012) 1.54

A review of the volatiles from the healthy human body. J Breath Res (2014) 1.46

Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. Small (2009) 1.33

Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J Chromatogr (1988) 1.28

Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat (2006) 1.26

Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev (2013) 1.23

Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta (2008) 1.21

Artificial noses. Annu Rev Biomed Eng (2011) 1.21

Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol (2012) 1.19

Solid-state gas sensors for breath analysis: a review. Anal Chim Acta (2014) 1.18

Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine (2011) 1.16

Classification of breast cancer precursors through exhaled breath. Breast Cancer Res Treat (2010) 1.12

A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine (2012) 1.09

Effects of ventilation on the collection of exhaled breath in humans. J Appl Physiol (1985) (2003) 0.98

Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study. Br J Cancer (2014) 0.94

Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. Analyst (2013) 0.90

Combined volatolomics for monitoring of human body chemistry. Sci Rep (2014) 0.87

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. BMC Pulm Med (2014) 0.85

Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Sci Rep (2014) 0.85

Breath analysis during one-lung ventilation in cancer patients. Eur Respir J (2012) 0.84

In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling. Lung Cancer (2012) 0.84

Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.82

Dead space: the physiology of wasted ventilation. Eur Respir J (2014) 0.79